超声在肝胆脾胰肾疾病普查中的临床价值  

Clinical Value of Ultrasound in General Survey of Hepatobiliary,Spleen,Pancreas and Kidney Diseases

作　　者：刘效榕 LIU Xiaorong(Hospital of Traditional Chinese Medicine,Benxi 117000,China)

机构地区：[1]辽宁省本溪市中医院,辽宁本溪117000

出　　处：《中国医药指南》2022年第2期96-98,共3页Guide of China Medicine

摘　　要：目的探讨超声在肝胆脾胰肾疾病普查中的临床价值,实现现有临床诊断方法的持续完善,以强化临床诊断方式的持续优化,满足现阶段肝胆脾胰肾疾病普查工作的开展要求。方法基于本次研究的定位,采取对照试验的方式,对比不同临床诊疗方案的实际应用效果。选取我院2018年4月至2019年4月收治的116例接受肝胆胰脾肾疾病普查患者,参照组采用抽血方式进行检查;试验组采用超声诊断进行检查:分析2种诊断方法对肝胆胰脾肾疾病的检出率情况。结果两组在诊断结果方面相比较,试验组检查出疾病的概率(肝脏13.79%、胆囊8.62%、脾脏10.34%、肾脏8.62%以及胰腺10.34%)高于参照组(肝脏5.17%、胆囊3.45%、脾脏3.45%、肾脏5.17%以及胰腺5.17%),差异有统计学意义(P<0.05)。两组在检查满意度方面相比较,试验组98.28%,参照组68.97%,差异有统计学意义(P<0.05)。结论针对肝胆脾胰肾疾病应用超声诊断可对良性病变、有明显特征的恶性病变进行诊断,超声诊断医疗费用低,安全性高,可重复性强,而且检测结果精准,可为医师提供有效诊断依据,进而制订合理化治疗方案,保证患者预后效果。Objective To explore the clinical value of ultrasound in the general survey of hepatobiliary,splenic,pancreatic and kidney diseases,to realize the continuous improvement of the existing clinical diagnosis methods,to strengthen the continuous optimization of clinical diagnosis methods,and to meet the requirements of the current general survey of hepatobiliary,splenic,pancreatic and kidney diseases.Methods Based on the orientation of this study,a controlled trial was adopted to compare the practical application effects of different clinical diagnosis and treatment schemes.A total of 116 patients with liver,bile,pancreas,spleen and kidney diseases admitted to our hospital from April 2018 to April 2019 were selected.Experimental group:ultrasonic diagnosis was used for examination:to analyze the detection rate of liver,bile,pancreas,spleen and kidney diseases by two diagnostic methods.Results The incidence of disease detection in the experimental group(liver 13.79%,gallbladder 8.62%,spleen 10.34%,kidney 8.62%and pancreas 10.34%)were higher than that in the control group(liver 5.17%,gallbladder 3.45%,spleen 3.45%,kidney 5.17%and pancreas 5.17%).There were significant differences(P<0.05).The satisfaction rate of the two groups was 98.28%in the experimental group and 68.97%in the reference group,with statistical significance(P<0.05).Conclusion Application of ultrasonic diagnosis for liver spleen pancreas kidney disease can be benign lesions,have obvious characteristics of malignant disease diagnosis,ultrasonic diagnostic medical expense is low,high safety,strong repeatability,precision and test result,can provide effective diagnosis basis for physicians,formulate the reasonable treatment,the prognosis of patients with guarantee effect.

关 键 词：肝胆脾胰肾疾病 超声 普查 临床价值 

分 类 号：R445.1[医药卫生—影像医学与核医学]